Extract to table

The Closing Date, as defined in the MCTA, is July 5, 2023, by which date certain closing deliverables — including the insurance certificates at issue in this memorandum — must be in process

Penterra's clinical trial liability insurance must name the following parties as additional insureds under the policy: • Veridian Health Research Network, Inc

The additional insured status of such parties is required to extend to claims arising from the CLARION trial that are subject to Penterra's indemnification obligations under Exhibit D

Thereafter, Penterra must deliver updated certificates of insurance to Veridian annually upon each renewal of the policy, and must provide at least thirty (30) days' prior written notice of any material change in, cancellation of, or non-renewal of the policy

Evidence of such coverage must be provided to Penterra within fifteen (15) business days of the execution of the MCTA, and annually thereafter upon policy renewal

Territory The Briarcliff Policy provides worldwide coverage for clinical trials conducted under the Named Insured's IND applications, subject to the requirement that any suit, action, or proceeding for which coverage is sought must be brought in the United States or its territories